MRVI IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure

Posted Apr 27 by Two Blokes

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds p

Source: Two Blokes Trading

This S&P 500 Stock Is Down 68%: Should You Buy It Now and Hold for 20 Years?

Posted Apr 27 by Two Blokes

Because of how well it represents the performance of the overall stock market, investors seem to always have t

Source: Two Blokes Trading

Decarbonization Efforts, AI Underpin WEC's Energy Growth

Posted Apr 27 by Two Blokes

I rate WEC a Buy due to its strategic alignment in AI-driven energy demand and clean energy transition, positi

Source: Two Blokes Trading

Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cance

Posted Apr 27 by Two Blokes

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YM

Source: Two Blokes Trading

2 Under-the-Radar AI Stocks With Market-Beating Potential

Posted Apr 27 by Two Blokes

The market is not favoring artificial intelligence (AI) stocks right now, as it is trying to de-risk itself by

Source: Two Blokes Trading

There's 1 Top AI Stock Insiders Keep Selling. Here's Why Shares Could Plummet 50% in a Market Crash.

Posted Apr 27 by Two Blokes

The Trump administration's ambitious tariff actions (and threats) have set off a level of volatility in the U.

Source: Two Blokes Trading

Prediction: 1 Stock That Will Be Worth More Than Nvidia 10 Years From Now

Posted Apr 27 by Two Blokes

Nvidia (NASDAQ: NVDA) is up over 18,000% in the last 10 years. It is one of the best-performing stocks in the

Source: Two Blokes Trading

Here's Why Berkshire Hathaway Stock Is a Buy Before May 2

Posted Apr 27 by Two Blokes

Berkshire Hathaway (BRK.A -0.33%) (BRK.B -0.11%) will likely report first-quarter 2025 earnings on or around M

Source: Two Blokes Trading

Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lu

Posted Apr 27 by Two Blokes

Zoldonrasib, a RAS(ON) G12D-selective inhibitor, demonstrated acceptable tolerability and encouraging initial

Source: Two Blokes Trading

APP INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that AppLovin Corporation Investors with Substantial Losses Ha

Posted Apr 27 by Two Blokes

SAN DIEGO, April 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that

Source: Two Blokes Trading

New Long-Term Follow-Up Data from OPTIMA II Study of UGN-102 Demonstrates Median Duration of Response of Two Years in Patients w

Posted Apr 27 by Two Blokes

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing

Source: Two Blokes Trading

ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Perpetua Resources Corp. Investors to Secure Counsel Before Important Deadl

Posted Apr 27 by Two Blokes

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds p

Source: Two Blokes Trading